IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
1.180
-0.020 (-1.67%)
At close: Nov 4, 2024, 4:00 PM
1.190
+0.010 (0.85%)
After-hours: Nov 4, 2024, 4:36 PM EST

IO Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-88-86.08-71.46-67.88-12.04-10.74
Depreciation & Amortization
0.820.760.540--
Stock-Based Compensation
7.768.067.041.790.060.13
Other Operating Activities
0.49-0.33-0.0426.221.870.83
Change in Accounts Payable
0.55-0.130.083.41-0.480.1
Change in Other Net Operating Assets
-2.315.994.12-4.180.620.79
Operating Cash Flow
-80.7-71.74-59.73-40.65-9.96-8.89
Capital Expenditures
-0.16-0.32-0.69-0.15--
Investing Cash Flow
-0.16-0.32-0.69-0.15--
Short-Term Debt Issued
-----9.01
Total Debt Issued
-----9.01
Net Debt Issued (Repaid)
-----9.01
Issuance of Common Stock
75.0675.06-115.12--
Other Financing Activities
-3.2-3.2--12.11-0.01-
Financing Cash Flow
71.8671.86-252.955.19.01
Foreign Exchange Rate Adjustments
-0.350.8-8.52-3.760.41-0.25
Net Cash Flow
-9.350.6-68.94208.39-4.44-0.13
Free Cash Flow
-80.86-72.06-60.42-40.8-9.96-8.89
Free Cash Flow Per Share
-1.30-1.66-2.10-9.41-56.19-50.17
Levered Free Cash Flow
-51.14-42.19-33.5-25.08-6.09-
Unlevered Free Cash Flow
-51.14-42.19-33.32-24.85-6.08-
Change in Net Working Capital
1.18-6.47-4.430.72-0.2-
Source: S&P Capital IQ. Standard template. Financial Sources.